Cargando…

Assessment of therapeutic response in patients with metastatic skeletal disease: suggested modifications for the MDA response classification criteria

Detalles Bibliográficos
Autores principales:	Vassiliou, V, Andreopoulos, D
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2010
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2966620/ https://www.ncbi.nlm.nih.gov/pubmed/20664592 http://dx.doi.org/10.1038/sj.bjc.6605825

Ejemplares similares

Reply: Assessment of therapeutic response in patients with metastatic skeletal disease: suggested modifications for the MDA response classification criteria
por: Hamaoka, T, et al.
Publicado: (2010)

The Maze of Vasodilator Response Criteria
por: Douwes, J. Menno, et al.
Publicado: (2010)

Comments on “Criteria for selection and classification of studies in medical events”
por: Pontes-Silva, André
Publicado: (2023)

Response to “Critical Analysis of Apixaban Dose Adjustment Criteria”
por: Mandt, Stephen R., et al.
Publicado: (2022)

Proposed Unifying Classification Criteria for Spinal Nerve Root Variations
por: Nikolenko, Vladimir N., et al.
Publicado: (2021)

Stiffened hang-back: A suggested modification using cyanoacrylate glue
por: Amitava, Abadan K., et al.
Publicado: (2015)

Response: Proposed Diagnostic Criteria for Definite Isolated Otolith Dysfunction
por: Suh, Myung-Whan, et al.
Publicado: (2021)

Modifications to predefined rapid response team calling criteria: prevalence, characteristics and associated outcomes
por: Chen, Qin Ting, et al.
Publicado: (2023)

Validation of response assessment according to international consortium for MDS/MPN criteria in chronic myelomonocytic leukemia treated with hypomethylating agents
por: Duchmann, M, et al.
Publicado: (2017)

Cancer Response Criteria and Bone Metastases: RECIST 1.1, MDA and PERCIST
por: Costelloe, Colleen M., et al.
Publicado: (2010)

Time to define common European criteria for therapeutic added value
por: Boucaud-Maitre, Denis, et al.
Publicado: (2022)

Expression of carbonic anhydrase IX suggests poor response to therapy in rectal cancer
por: Span, P N, et al.
Publicado: (2009)

Violence against doctors; Suggested additional solutions- response to Patil et al.
por: Sinha, Kanishk, et al.
Publicado: (2021)

Including myositis-specific autoantibodies improves performance of the idiopathic inflammatory myopathies classification criteria
por: To, Fergus, et al.
Publicado: (2019)

CONGENITAL CYSTIC DILATATIONS OF THE BILE DUCTS: ATTEMPT FOR MODIFICATION IN CLASSIFICATION
por: NARI, Gustavo Adrian, et al.
Publicado: (2021)

Reply: expression of carbonic anhydrase IX suggests poor response to therapy in rectal cancer
por: Korkeila, E, et al.
Publicado: (2009)

Response to the letter: “On the localization of ClC-1 in skeletal muscle fibers”
por: Lueck, John D., et al.
Publicado: (2011)

Response to: Incidence and Skeletal Features of Developmental Cervical and Lumbar Spinal Stenosis
por: Kasai, Yuichi, et al.
Publicado: (2023)

Relationship of different platelet response criteria and patient outcomes in a romiplostim myelodysplastic syndromes trial
por: Platzbecker, U, et al.
Publicado: (2014)

The Lie Effect: A Factor Responsible for Perceived Therapeutic Response
por: Kar, Sujita Kumar
Publicado: (2018)

Modifications to the HEALing Communities Study in response to COVID-19 related disruptions
por: Walters, Scott T., et al.
Publicado: (2021)

Response to ‘The evolving mystery of why skeletal muscle is spared in seropositive neuromyelitis optica’
por: Frigeri, Antonio, et al.
Publicado: (2018)

Thoracic ultrasound: Possible complementary criteria for the assessment of pulmonary fibrosis
por: Trovato, Guglielmo M., et al.
Publicado: (2014)

Phase III trial of docetaxel cisplatin 5‐fluorouracil induction chemotherapy for resectable oral cancer suggests favorable pathological response as a surrogate endpoint for good therapeutic outcome
por: Ju, Wu‐tong, et al.
Publicado: (2021)

The First Case of Therapy-Related Myelomastocytic Leukemia Based on the WHO 2008 Classification and the Recently Proposed Diagnostic Criteria
por: Choi, Won-Kyu, et al.
Publicado: (2017)

The impact of reclassification by the 2022 ACR/EULAR classification criteria on risk factors for relapse in patients with ANCA-associated vasculitis
por: van Leeuwen, Jolijn R, et al.
Publicado: (2023)

Response to Michael Wonder’s comments on the article ‘Assessment of the therapeutic value of new medicines marketed in Australia’
por: Vitry, Agnes I
Publicado: (2013)

Cavefish mount a rapid and sustained regenerative response following skeletal muscle injury
por: Olsen, Luke, et al.
Publicado: (2023)

On the authorship criteria
por: Rakhshan, Vahid
Publicado: (2014)

Long-lasting response to third-line chemotherapy in metastatic pancreatic cancer
por: Tavares, Alda, et al.
Publicado: (2020)

Some Suggestions.........
por: Shamasundar, C
Publicado: (2004)

Response to “Modifications to the PREEMPT Protocol for OnabotulinumtoxinA Injections for Chronic Migraine in Clinical Practice”
por: Blumenfeld, Andrew M., et al.
Publicado: (2020)

Diagnosis of Ineffective Esophageal Motility According to Chicago Classification Version 4.0: More Stringent Criteria, but Also New Difficulties
por: Ruggiero, Luigi, et al.
Publicado: (2023)

A response to “Response to a Trial on Reversal of Death by Neurologic Criteria”
por: Pastor, Ira S.
Publicado: (2017)

Mechanic’s Hand Heralding Relapse in an Indian Adolescent with Anti-MDA5 Positive Juvenile Dermatomyositis
por: Ganatra, Keya, et al.
Publicado: (2022)

Building a trusted framework for uncertainty assessment in rare diseases: suggestions for improvement (Response to “TRUST4RD: tool for reducing uncertainties in the evidence generation for specialised treatments for rare diseases”)
por: Grimm, Sabine E., et al.
Publicado: (2021)

Jaccoud-type lupus arthropathy: practical classification criteria
por: Santiago, Mittermayer
Publicado: (2020)

Cetuximab Related Eyelash Elongations for Patients with Metastatic Rectum Carcinoma: Metabolic Complete Response
por: Ürün, Yüksel, et al.
Publicado: (2013)

Patient‐derived organoids in cellulosic sponge model chemotherapy response of metastatic colorectal cancer
por: Xu, Yanjie, et al.
Publicado: (2021)

Immune combinations and complete response: a new hope for metastatic renal cell carcinoma
por: Catalano, Martina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3b0rg4ifbpc68om0c4mnd2a15f